Publication

Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Mirna Tenan, University Hospital (CHUV), SwitzerlandGiulia Fulci, University Hospital (CHUV), SwitzerlandMichele Albertoni, University Hospital (CHUV), SwitzerlandAnnie-Claire Diserens, University Hospital (CHUV), SwitzerlandMarie-France Hamou, University Hospital (CHUV), SwitzerlandMichele El Atifi-Borel, University Hospital (CHRG), FranceJean-Jacques Feige, Commissariat à l'Énergie Atomique (CEA), FranceMichael S. Pepper, University of Geneva Medical Center, SwitzerlandErwin Van Meir, Emory University
Language
  • English
Date
  • 2000-05-15
Publisher
  • Rockefeller University Press
Publication Version
Copyright Statement
  • © 2000 The Rockefeller University Press
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0022-1007
Volume
  • 191
Issue
  • 10
Start Page
  • 1789
End Page
  • 1798
Grant/Funding Information
  • This work was supported by the Italian Association for Cancer Research (to M. Tenan), Swiss National Science Foundation grants 31-49194.96 and 4037-044729, Swiss Cancer Research Foundation grant KFS172-9-1995, National Institutes of Health grant CA86335, and the San Salvatore Foundation (all to E.G. Van Meir), and by MBNA America Bank, N.A.
Abstract
  • Angiogenesis, the sprouting of new capillaries from preexisting blood vessels, results from a disruption of the balance between stimulatory and inhibitory factors. Here, we show that anoxia reduces expression of thrombospondin-1 (TSP-1), a natural inhibitor of angiogenesis, in glioblastoma cells. This suggests that reduced oxygen tension can promote angiogenesis not only by stimulating the production of inducers, such as vascular endothelial growth factor, but also by reducing the production of inhibitors. This downregulation may significantly contribute to glioblastoma development, since we show that an increase in TSP-1 expression is sufficient to strongly suppress glioblastoma cell tumorigenicity in vivo.
Author Notes
  • Erwin G. Van Meir, Laboratory of Molecular Neuro-Oncology, Winship Cancer Institute, Emory University, 1365-B Clifton Rd. NE, Rm. B5103, Atlanta, GA 30322., Phone: 404-778-5227, Fax: 404-778-5240. Erwin G. Van Meir: ude.yrome@iemnave
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items